Christopher J. Duncan, DPhil

Translational and Clinical Research Institute, Newcastle University and NIHR Newcastle Clinical Research Facility, The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom

Poster(s):

• (2363) Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET